blogs created to prevent or detect a crime

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime

Monday, 2 July 2012

Jon Jureidini - PAXIL Seroxat study paid for by Scientology linked lawyers Baum Hedlund - see FIDDAMAN blog

Jon Jureidini


Title: Clinical Professor

Position: Head, Department of Psychological Medicine, Women's & Children's Hospital: Senior Research Fellow, Department of Philosophy, Flinders University of South Australia

Professional Affiliations:

Healthy Skepticism (

Women's and Children's Hospital Patient Care Ethics Group

Teaching Interests:

Clinical Appraisal, child development, psychiatric diagnosis

Clinical Interests:

Consultation-Liaison Psychiatry, Medicine and the pharmaceutical industry

Research Interests:

Suicide and antidepressants; language and communication in medicine

Key Publications:

Jureidini, J. (2009) How do we safely treat depression in children, adolescents and young adults? Drug Safety 32(4): 275-282.

Jureidini, J. (2008). Mind magic. In Rethinking ADHD: International Perspectives. timimi, S., Leo J (Eds). London: Palgrave Macmillan.

Jureidini, J., McHenry, L., Mansfield, P. (2008) Clinical Trials and Drug Promotion : Selective Reporting of Study 329. International Journal of Risk and Safety in Medicine 20: 73-81

Mares S & Jrueidini J, 2004. Psychiatric assessment of children and families in immigration detention? Clinical, administrative and ethical issues. Australian Journal of Public Health 28:520-6.

Donald T & Jureidini J, 2004. Parenting Capacity , 13:5-17

National and International Collaborations:

Canadian Womens' Health Network. SSRI use in pregnancy.

Declaration of Financial Interest:

In the last 5 years, Jon Jureidini has accepted no fees or other remuneration from drug companies, nor does he hold any shares. He was engaged by Baum Hedlund to provide an independent analysis of the data of GSKs Study 329 of paroxetine.

Contact Details:

Telephone: +61 8 8161 7226

Facsimile: +61 8 8161 7032


No comments:

Post a Comment

Note: only a member of this blog may post a comment.